RTW INVESTMENTS, LP

Position in CGON — CG Oncology, Inc.

CIK 1493215 NEW YORK, NY

Position in CGON

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$604,961,619

+$132,229,814 QoQ

Shares Held

8,514,590

+21.9% QoQ

Ownership

9.61%

of shares outstanding

% of Portfolio

5.16%

of 13F equity value

Holder Rank

of 226 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. CGON ranks #5 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	1,993,687	$1,070,510,234
2	ARGX	Argenx SE	709,446	$658,202,715
3	PTCT	Ptc Therapeutics, Inc.	7,746,415	$631,875,071
4	PTGX	Protagonist Therapeutics, Inc	5,061,175	$620,398,831
5	CGON	CG Oncology, Inc. This page	8,514,590	$604,961,619
6	INSM	INSMED Inc	4,842,880	$516,347,865
7	TNGX	Tango Therapeutics, Inc.	13,900,620	$434,533,381
8	SYRE	Spyre Therapeutics, Inc.	4,251,996	$377,492,204

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$604,961,619	8,514,590	+21.9%	Shares	Sole	2026-08-14
2026-06-30	$604,961,619	8,514,590	—	Shares	Sole	2026-08-14
2026-03-31	$472,731,805	6,984,808	+247.1%	Shares	Sole	2026-05-15
2025-12-31	$83,543,513	2,012,127	+18.3%	Shares	Sole	2026-02-17
2025-09-30	$68,524,980	1,701,216	0.0%	Shares	Sole	2025-11-14
2025-06-30	$44,231,616	1,701,216	0.0%	Shares	Sole	2025-08-14
2025-03-31	$41,662,779	1,701,216	0.0%	Shares	Sole	2025-05-15
2024-12-31	$48,790,874	1,701,216	+26.6%	Shares	Sole	2025-02-14
2024-09-30	$50,711,912	1,344,074	0.0%	Shares	Sole	2024-11-14
2024-06-30	$42,432,416	1,344,074	+224.9%	Shares	Sole	2024-08-14
2024-03-31	$18,160,113	413,670	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.